Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

IPA - ImmunoPrecise Antibodies Ltd


IEX Last Trade
0.755
-0.010   -1.272%

Share volume: 34,765
Last Updated: Fri 30 Aug 2024 09:59:38 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$0.76
-0.01
-1.26%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
-6.79%
1 Month
-9.04%
3 Months
-31.36%
6 Months
-58.29%
1 Year
-60.47%
2 Year
-86.02%
Key data
Stock price
$0.76
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$0.58 - $2.60
52 WEEK CHANGE
-$0.63
MARKET CAP 
20.613 M
YIELD 
N/A
SHARES OUTSTANDING 
27.302 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
09/12/2024
BETA 
1.07
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$51,092
AVERAGE 30 VOLUME 
$115,110
Company detail
CEO:
Region: US
Website: http://www.immunoprecise.com/
Employees: 66
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

immunoprecise antibodies is a highly specialized customer focused life sciences company that provides custom antibody development and immunology services from its headquarters in beautiful victoria, bc, canada. our dedication to advancing antibody development has resulted in cutting-edge immunological innovations such as single-step cloning, rapid prime immunization strategies, and recombinant monoclonal technology. we pride ourselves on our high customer satisfaction and our clients have grown accustomed to receiving thorough and professional service. we customize your project to generate antibodies that meet your specific needs. over our 20+ year history, we have gained the trust of a diverse group of customers that include research agencies, universities, biotechnology and pharmaceutical companies of all sizes from around the globe. immunoprecise is pleased to announce its newest line of services, immunoprotect™. with immunoprotect™, the dna sequence of your mab is determined and ca

Recent news